Research - , ,
ADvantage Therapeutics, Inc. is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer's Disease (AD). We are currently preparing for Phase 2 clinical trials in Europe. Furthermore, ADvantage is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.
Outlook
Cloudflare DNS
WordPress.org
Mobile Friendly
CloudFlare Hosting